Sunday, July 4, 2021

Pfizer, Moderna vaccines may soon be available in India

The Drugs Controller General of India (DCGI) has given a green signal to foreign vaccines to be approved in India without specific clinical trials in the country before usage. This could be a big step in making vaccination drive a bigger success.DCGI Chief, VG Somani letter said that this will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for Emergency Use by the World Health Organisation.

“In order to make vaccines available to the Indian population at the earliest and fulfill need for vaccine imports… it has been decided that for approval of Covid-19 Vaccines in India for restricted use in emergency situation which are already approved for restricted use by US FDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO Emergency Use listing,” he told ANI.

Somani said that conducting post-approval clinical trials and testing each batch by the Central Drugs Laboratory (CDL), Kasauli can be exempted for the vaccines which are already in use by millions of people worldwide. The specific trials will no longer be in need if the vaccine batch/lot has been certified and released by the National Control Laboratory of the Country of Origin.

Earlier, vaccines that had completed clinical studies outside the country were required to carry out “bridging trials” or limited clinical trials on the Indian population to know how the drug works on people of Indian origin.

“The scrutiny and review of their Summary Lot Protocol and Certificate of the analysis of Batch/Lot Shall be undertaken by CDL Kasauli for batch release as per standard procedures and the requirement of assessment of the first 100 beneficiaries for 7 days for safety outcomes before the vaccine is rolled out (for) further immunization programs, along with other procedures for filing of applications and timeline for processing of the applications, etc, as laid down in the notice dated 15.04.21 shall remain the same.” Dr Somani said in the letter.

Source: health.economictimes.indiatimes.com

For latest healthcare industry update, click here.

For healthy living articles, click here.

To develop corporate skills, click here.

To download free E-Books, click here.

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...